VELCADE*EV 1FL 3,5MG 1MG/ML ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
61	Autoimmune hemolytic anemia	1

61. Autoimmune hemolytic anemia

Clinical trials : 146 / Drugs : 131 - (DrugBank : 59) / Drug target genes : 28 - Drug target pathways : 158

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-006329-42-IT (EUCTR)	11/10/2012	30/10/2012	Short treatment with a drug for patients affected by a type of a treatment-resistant anaemia, where ...	Short course of Bortezomib in anemic patients with refractory cold agglutinin disease	Anaemia with refractory cold agglutinin disease MedDRA version: 14.1;Level: PT;Classification code 1 ...	Trade Name: VELCADE*EV 1FL 3,5MG 1MG/ML	G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 2	Italy

First Previous1Next Last